Decoy Therapeutics (DCOY) traded down -5.83 % during a 24 hours period ending at 04:23 PM Central Europe on Monday 26th. One Decoy Therapeutics stock can currently be bought for about USD 0.93 on popular exchanges. Current supply of Decoy Therapeutics stocks is 655.2 k. Decoy Therapeutics has a current market capitalization of USD 635.5 k and approximately USD 36.2 k worth of Decoy Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Decoy Therapeutics has traded -68.81 % down. Simple moving average of last 200 days is at USD 5.76. The highest price of past 52 weeks was recorded at USD 47.28 on 10/31/2025. 52 weeks low was at USD 0.96 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Profusa (PFSA) traded down -17.75 % and now trades at USD 0.75. Profusa has a market capitalisation of USD 508.2 k.
Stardust Power (SDST) traded down -53.85 % and now trades at USD 0. Stardust Power has a market capitalisation of USD 507.2 k.
Renalytix (RENX.L) traded up 3.45 % and now trades at GBX 5.95. Current market capitalisation for Renalytix is GBX 53.8 mn.
Onfolio (ONFO) traded down -3.08 % and now trades at USD 0.45. Onfolio has a market capitalisation of USD 428.1 k.
Lakewood-amedex Biotherapeut (LABT) traded down -36.73 % and now trades at USD 0.27. Lakewood-amedex Biotherapeut has a market capitalisation of USD 734.6 k.
About Decoy Therapeutics
Salarius Pharmaceuticals Inc is a clinical-stage oncology company that specializes in targeting the epigenetic causes of cancers and developing treatments for patients. Based in Houston, Texas, the United States, the company serves State of Texas residents. You can learn more about their offerings by visiting their website at www.salariuspharma.com . Nasdaq is where their stocks are traded and they went public on January 29, 2015.
